Imperial Ginseng Products Ltd.
IGPFFOTCConsumer Defensive
$0.71
+$0.65(+1068.60%)
Market Cap$5410353
P/E Ratio—
52W High$0.707
52W Low$0.0499
Imperial Ginseng Products Ltd. (IGPFF) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · IGPFF · as of 2026-06-09
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2024-06 | 2023-06 | 2022-06 | 2021-06 | 2020-06 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $0.00B | $0.00B | $0.00B | $0.01B | $0.01B |
| Cost of Revenue | $0.00B | $0.00B | $0.00B | $0.01B | $0.01B |
| Gross Profit | $0.00B | $0.00B | ($0.00B) | $0.00B | $0.00B |
| Gross Margin %(computed) | — | 1.17% | -5.98% | 2.49% | 2.72% |
| Operating Expenses | |||||
| R&D Expenses | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| G&A Expenses | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Total Operating Expenses | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Operating Income | ($0.00B) | ($0.00B) | ($0.00B) | ($0.00B) | ($0.01B) |
| Operating Margin %(computed) | — | -47.65% | -85.74% | -14.42% | -140.13% |
| Interest Income | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Interest Expense | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Income Before Tax | $0.00B | $0.00B | $0.00B | ($0.01B) | ($0.01B) |
| Income Tax Expense | $0.00B | $0.00B | $0.00B | ($0.00B) | ($0.00B) |
| Net Income | $0.00B | $0.00B | $0.00B | ($0.00B) | ($0.01B) |
| Net Margin %(computed) | — | 67.84% | 67.31% | -62.28% | -127.06% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $0.03 | $0.38 | $0.31 | $-0.61 | $-1.00 |
| Wtd Avg Shares | 0.01B | 0.01B | 0.01B | 0.01B | 0.01B |
| EBITDA | ($0.00B) | $0.00B | $0.00B | ($0.01B) | ($0.01B) |
| EBITDA Margin %(computed) | — | 97.19% | 92.68% | -74.14% | -166.97% |
Data source: Financial Modeling Prep · Last updated: 2026-06-09 · CAD · B
Explore more Imperial Ginseng Products Ltd. data
About Imperial Ginseng Products Ltd. (IGPFF) Income Statement
Imperial Ginseng Products Ltd. (IGPFF) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2024, IGPFF reported revenue of $0.00B, gross profit of $0.00B (gross margin —), and net income of $0.00B — a net profit margin of —.
Frequently asked questions
IGPFF · 4 questionsImperial Ginseng Products Ltd. (IGPFF) reported revenue of $0.00B for 2024, down 100.0% year-over-year.
IGPFF revenueIGPFF salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09